Kto publikuje wyniki i kiedy, na najbliższe tygodnie. Kalendarz pochodzi ze źródła zewnętrznego; każdą liczbę obok — ocenę, wielkość, wskaźnik — liczymy z własnych raportów spółki złożonych do SEC.
W tym miesiącu zaplanowane 2363 spółki, z czego 2330 pokrywamy.
| Spółka | Ocena | Wielkość | C/Z | Dane |
|---|---|---|---|---|
B | 73,3B USD | 10,86 | — | |
B | 3,8B USD | 22,00 | — | |
F | 3,4B USD | — | — | |
C | 1,5B USD | 17,22 | — |
| Spółka | Ocena | Wielkość | C/Z | Dane |
|---|---|---|---|---|
A | 253,2B USD | 23,60 | — | |
A | 122,3B USD | 34,08 | — | |
A | 98,9B USD | 537,23 | — | |
B | 98,2B USD | 12,96 | — | |
A | 94,4B USD | — | — | |
| 89B USD |
| 17,49 |
| — |
D | 81,2B USD | — | — |
F | 77,5B USD | — | — |
A | 71,8B USD | 26,64 | — |
F | 62,2B USD | — | — |
A | 61,4B USD | 41,80 | — |
A | 60,7B USD | 25,28 | — |
B | 59,7B USD | — | — |
B | 49,6B USD | 54,82 | — |
A | 47,9B USD | 40,40 | — |
B | 47,3B USD | 23,79 | — |
A | 44,3B USD | 132,30 | — |
C | 42,8B USD | 115,85 | — |
A | 41,6B USD | 65,38 | — |
A | 40,9B USD | — | — |
B | 38,1B USD | 17,42 | — |
| TTWO | B | 37,9B USD | — | — |
| CHT | C | 35,4B USD | 30,35 | — |
| EXPE | A | 33B USD | 16,58 | — |
| MTD | A | 30,8B USD | 34,65 | — |
| PBA | D | 25,9B USD | 23,75 | — |
| SN | A | 25,7B USD | 36,92 | — |
| AFRM | A | 24,2B USD | 12,54 | — |
| TPR | A | 22,7B USD | 15,62 | — |
| RL | B | 21,8B USD | 22,43 | — |
| MTSI | A | 21,7B USD | 90,62 | — |
| VTRS | C | 20,8B USD | — | — |
| NRG | B | 20,4B USD | 25,50 | — |
| USFD | B | 20,3B USD | 28,84 | — |
| BCE | B | 18,7B USD | 4,21 | — |
| EVRG | D | 18,1B USD | 20,94 | — |
| DD | B | 17,6B USD | 153,07 | — |
| LNT | D | 16,6B USD | 20,17 | — |
| NWSA | A | 15,9B USD | 27,68 | — |
| AKAM | B | 15,6B USD | 39,15 | — |
| TIGO | A | 15,5B USD | 11,72 | — |
| SOLV | F | 15,2B USD | 10,94 | — |
| RBA | B | 15,1B USD | 35,08 | — |
| ONTO | B | 15B USD | 114,54 | — |
| LAMR | A | 14,8B USD | 26,64 | — |
| IREN | D | 14,8B USD | — | — |
| SGI | A | 13,1B USD | 24,80 | — |
| GEN | A | 12,5B USD | 12,19 | — |
| QXO | B | 12B USD | — | — |
| CIB | Bez oceny | 11,9B USD | — | — |
| TXG | C | 11,6B USD | — | — |
| AHR | B | 11,4B USD | 76,59 | — |
| NVMI | A | 11,3B USD | 48,38 | — |
| FROG | A | 11,1B USD | — | — |
| FNF | B | 11B USD | 14,30 | — |
| SUZ | A | 10,8B USD | 4,10 | — |
| GSAT | B | 10,6B USD | — | — |
| TXRH | A | 10,3B USD | 25,17 | — |
| GMED | A | 10,2B USD | 19,42 | — |
| CPT | B | 9,9B USD | 32,60 | — |
| OSCR | A | 9,9B USD | 22,90 | — |
| DKNG | A | 9,7B USD | — | — |
| WMS | B | 9,7B USD | 22,21 | — |
| PODD | B | 9,2B USD | 24,88 | — |
| PTGX | A | 9,1B USD | 138,17 | — |
| AAOI | D | 8,5B USD | — | — |
| MP | F | 8,1B USD | — | — |
| WYNN | A | 8,1B USD | 18,76 | — |
| DBX | A | 7,6B USD | 18,17 | — |
| AAON | C | 7B USD | 44,54 | — |
| CELH | A | 7B USD | 120,52 | — |
| GPCR | Bez oceny | 7B USD | — | — |
| PRMB | A | 7B USD | 71,33 | — |
| VCTR | A | 6,8B USD | 20,19 | — |
| IOVA | B | 6,5B USD | — | — |
| LNTH | A | 6,5B USD | 24,10 | — |
| STVN | C | 6,4B USD | 36,63 | — |
| LGND | A | 6,2B USD | 32,98 | — |
| QBTS | F | 6,1B USD | — | — |
| TTD | A | 5,7B USD | 14,51 | — |
| TKC | A | 5,5B USD | — | — |
| EPAM | C | 5,5B USD | 14,53 | — |
| BGC | A | 5,5B USD | 27,95 | — |
| INSW | B | 5,5B USD | 7,06 | — |
| G | B | 5,4B USD | 9,57 | — |
| TFX | C | 5,4B USD | — | — |
| MRX | B | 5,3B USD | — | — |
| MAIN | Bez oceny | 5,2B USD | 14,27 | — |
| DFTX | Bez oceny | 5,1B USD | — | — |
| GVA | A | 5,1B USD | — | — |
| DOCS | A | 5,1B USD | 31,20 | — |
| HRB | A | 5B USD | 7,17 | — |
| NXST | C | 5B USD | 30,64 | — |
| OUT | A | 4,9B USD | 19,99 | — |
| CE | D | 4,9B USD | — | — |
| HIMX | F | 4,9B USD | 108,54 | — |
| ACIW | A | 4,9B USD | 22,28 | — |
| WTM | B | 4,8B USD | 4,63 | — |
| HAE | A | 4,8B USD | 51,14 | — |
| MIDD | C | 4,8B USD | — | — |
| VSNT | F | 4,6B USD | — | — |
| HASI | C | 4,6B USD | 61,28 | — |
| LFST | A | 4,5B USD | — | — |
| ABCL | D | 4,5B USD | — | — |
| CON | A | 4,5B USD | 22,80 | — |
| DIOD | C | 4,5B USD | 52,24 | — |
| NNI | B | 4,5B USD | 14,82 | — |
| KRMN | C | 4,4B USD | 113,34 | — |
| CNR | B | 4,3B USD | 43,47 | — |
| IBOC | A | 4,3B USD | 10,40 | — |
| EWTX | Bez oceny | 4,3B USD | — | — |
| COLD | D | 4,2B USD | — | — |
| ICUI | C | 4,1B USD | 137,28 | — |
| GEO | B | 4,1B USD | 14,53 | — |
| RLAY | C | 4B USD | — | — |
| SYNA | D | 3,9B USD | — | — |
| MDU | F | 3,9B USD | 19,67 | — |
| MSGE | A | 3,9B USD | 59,30 | — |
| ACHR | D | 3,9B USD | — | — |
| CENX | A | 3,6B USD | 6,25 | — |
| BILL | A | 3,6B USD | — | — |
| STEP | D | 3,5B USD | — | — |
| TAC | D | 3,5B USD | — | — |
| OLED | B | 3,5B USD | 18,40 | — |
| WRBY | B | 3,5B USD | 392,57 | — |
| RXO | D | 3,4B USD | — | — |
| MWA | A | 3,4B USD | 15,12 | — |
| LION | C | 3,3B USD | — | — |
| DNLI | F | 3,3B USD | — | — |
| NHI | D | 3,3B USD | 19,27 | — |
| AMLX | D | 3,3B USD | — | — |
| PLMR | A | 3,2B USD | 16,57 | — |
| WSC | D | 3,2B USD | — | — |
| YETI | A | 3,1B USD | 18,58 | — |
| CPK | C | 3,1B USD | 20,43 | — |
| AGO | B | 3B USD | 9,20 | — |
| FA | A | 3B USD | 125,93 | — |
| BHF | B | 3B USD | 4,15 | — |
| CARG | B | 2,9B USD | 16,93 | — |
| AVPT | A | 2,9B USD | 42,44 | — |
| FG | B | 2,9B USD | 7,42 | — |
| NTCT | C | 2,8B USD | 23,93 | — |
| DXPE | A | 2,8B USD | 32,10 | — |
| GRND | A | 2,8B USD | 32,22 | — |
| STNE | Bez oceny | 2,8B USD | — | — |
| AVAH | A | 2,8B USD | 10,14 | — |
| MBX | Bez oceny | 2,8B USD | — | — |
| EFXT | B | 2,8B USD | 43,60 | — |
| FIGS | A | 2,8B USD | 42,64 | — |
| SMR | F | 2,7B USD | — | — |
| ALRM | A | 2,6B USD | 23,83 | — |
| BKD | B | 2,6B USD | — | — |
| APPN | A | 2,6B USD | — | — |
| DCO | C | 2,6B USD | — | — |
| FIVN | A | 2,5B USD | 49,26 | — |
| IRON | Bez oceny | 2,5B USD | — | — |
| CALY | B | 2,5B USD | — | — |
| PRVA | B | 2,5B USD | 93,48 | — |
| IMNM | F | 2,5B USD | — | — |
| ATHM | F | 2,5B USD | 12,12 | — |
| NOG | D | 2,4B USD | — | — |
| SVM | A | 2,4B USD | 38,66 | — |
| NN | F | 2,3B USD | — | — |
| PLUS | D | 2,3B USD | 18,86 | — |
| DNN | D | 2,3B USD | — | — |
| LPG | A | 2,3B USD | 7,18 | — |
| OPEN | F | 2,3B USD | — | — |
| INOD | A | 2,3B USD | 50,68 | — |
| LASR | A | 2,3B USD | — | — |
| PBH | C | 2,2B USD | 13,10 | — |
| BBUC | C | 2,2B USD | — | — |
| PTON | C | 2,2B USD | 36,00 | — |
| HCI | B | 2,2B USD | 7,61 | — |
| AMR | F | 2,1B USD | — | — |
| PDFS | C | 2,1B USD | 199,04 | — |
| CC | C | 2,1B USD | — | — |
| VCEL | A | 2,1B USD | 86,44 | — |
| NKTR | F | 2B USD | — | — |
| STGW | B | 2B USD | — | — |
| CCU | B | 2B USD | 11,94 | — |
| GENB | Bez oceny | 2B USD | — | — |
| ASTH | B | 2B USD | 42,73 | — |
| URGN | C | 2B USD | — | — |
| PENN | B | 2B USD | — | — |
| ZD | C | 1,9B USD | 3,19 | — |
| ALG | B | 1,9B USD | 19,04 | — |
| ZYME | F | 1,9B USD | — | — |
| TH | C | 1,9B USD | — | — |
| BLFS | A | 1,9B USD | 33,54 | — |
| PGNY | B | 1,9B USD | 26,96 | — |
| LMAT | B | 1,9B USD | 29,10 | — |
| USAR | D | 1,9B USD | — | — |
| RUN | B | 1,9B USD | 5,22 | — |
| MLCO | A | 1,9B USD | 9,89 | — |
| GCT | B | 1,8B USD | 11,95 | — |
| UAA | D | 1,8B USD | — | — |
| XERS | F | 1,8B USD | — | — |
| BOBS | Bez oceny | 1,8B USD | — | — |
| XRAY | D | 1,8B USD | — | — |
| NVAX | D | 1,8B USD | — | — |
| NFE | D | 1,7B USD | — | — |
| MNR | B | 1,7B USD | 17,32 | — |
| ETON | A | 1,7B USD | — | — |
| NTLA | C | 1,7B USD | — | — |
| STRA | A | 1,7B USD | 12,65 | — |
| CBL | B | 1,7B USD | 7,75 | — |
| EVTC | A | 1,6B USD | 17,57 | — |
| RAPP | Bez oceny | 1,6B USD | — | — |
| IMCR | C | 1,6B USD | — | — |
| AMBQ | D | 1,6B USD | — | — |
| GHRS | Bez oceny | 1,5B USD | — | — |
| BL | A | 1,5B USD | 46,23 | — |
| MAZE | F | 1,5B USD | — | — |
| NOMD | C | 1,5B USD | 10,16 | — |
| HUN | C | 1,5B USD | — | — |
| PRKS | D | 1,5B USD | 12,57 | — |
| LSPD | A | 1,4B USD | — | — |
| EVCM | C | 1,4B USD | 42,37 | — |
| CERT | D | 1,4B USD | — | — |
| DMLP | B | 1,4B USD | — | — |
| AMPX | D | 1,4B USD | — | — |
| AMN | B | 1,4B USD | 12,99 | — |
| ARHS | B | 1,3B USD | 18,93 | — |
| ARLO | A | 1,3B USD | 44,43 | — |
| DMRA | Bez oceny | 1,3B USD | — | — |
| GOLD | A | 1,3B USD | 14,89 | — |
| WD | B | 1,2B USD | 32,39 | — |
| CRON | A | 1,2B USD | 16,90 | — |
| UMAC | D | 1,2B USD | — | — |
| REPL | Bez oceny | 1,2B USD | — | — |
| FLO | A | 1,2B USD | 14,23 | — |
| LBRX | Bez oceny | 1,2B USD | — | — |
| MSDL | Bez oceny | 1,2B USD | 20,64 | — |
| CCO | B | 1,2B USD | — | — |
| OMDA | A | 1,2B USD | 84,17 | — |
| SCSC | B | 1,2B USD | 15,91 | — |
| TNDM | B | 1,2B USD | — | — |
| WLDN | B | 1,2B USD | 17,77 | — |
| AMPH | A | 1,1B USD | 15,80 | — |
| MRVI | D | 1,1B USD | — | — |
| AORT | D | 1,1B USD | — | — |
| PSEC | Bez oceny | 1,1B USD | 21,05 | — |
| PSIX | B | 1,1B USD | 16,04 | — |
| GSBD | Bez oceny | 1,1B USD | 18,27 | — |
| NRDY | C | 1,1B USD | — | — |
| LOMA | D | 1,1B USD | 10,58 | — |
| ENOV | A | 1,1B USD | — | — |
| SG | B | 1,1B USD | 87,40 | — |
| KRT | B | 1,1B USD | 21,08 | — |
| TRUP | A | 1B USD | 44,58 | — |
| JANX | B | 1B USD | — | — |
| PCRX | A | 1B USD | 73,34 | — |
| RXT | D | 1B USD | — | — |
| GLUE | D | 1B USD | — | — |
| YELP | B | 993M USD | 8,76 | — |
| TRIP | D | 983,9M USD | 139,92 | — |
| CGEM | Bez oceny | 980,8M USD | — | — |
| EDN | D | 939,8M USD | 5,08 | — |
| KODK | B | 938,9M USD | — | — |
| VYX | F | 914M USD | 15,24 | — |
| KRO | D | 913,9M USD | — | — |
| BBDC | Bez oceny | 913M USD | 7,79 | — |
| ASM | A | 912,2M USD | 31,22 | — |
| BKSY | D | 895,4M USD | — | — |
| PCT | C | 891M USD | — | — |
| SHAZ | Bez oceny | 886,1M USD | — | — |
| SANA | Bez oceny | 874,1M USD | — | — |
| RPC | B | 870,3M USD | 30,63 | — |
| CIM | Bez oceny | 854,7M USD | — | — |
| SGP | Bez oceny | 851,3M USD | — | — |
| LXRX | C | 838,7M USD | — | — |
| AVTX | F | 834,2M USD | — | — |
| BLZE | A | 828,2M USD | — | — |
| QNST | A | 824,3M USD | 10,24 | — |
| PLTK | C | 822M USD | — | — |
| GRPN | D | 813,3M USD | — | — |
| MFA | C | 809,7M USD | 7,93 | — |
| HSHP | A | 804,2M USD | 15,26 | — |
| NABL | B | 793,4M USD | — | — |
| WEST | B | 792,2M USD | — | — |
| ACHV | Bez oceny | 791,8M USD | — | — |
| ABX | A | 787,7M USD | 29,83 | — |
| FOXF | F | 786M USD | — | — |
| MTUS | F | 780,5M USD | 94,15 | — |
| LYTS | B | 777,6M USD | 31,15 | — |
| ACRS | D | 777,2M USD | — | — |
| GOOS | B | 756,6M USD | 11,28 | — |
| BFS | D | 744,5M USD | 30,73 | — |
| FDUS | Bez oceny | 741,1M USD | 9,04 | — |
| MLAB | A | 730,4M USD | 153,55 | — |
| MFIC | Bez oceny | 729,8M USD | — | — |
| COLL | A | 723,4M USD | 17,92 | — |
| PHAR | A | 714M USD | 254,38 | — |
| BLMN | B | 689,2M USD | 25,16 | — |
| APC | Bez oceny | 669,4M USD | — | — |
| PZZA | F | 669,3M USD | 25,73 | — |
| VTEX | A | 666,4M USD | 21,30 | — |
| OFRM | Bez oceny | 664,1M USD | — | — |
| DNA | D | 663,8M USD | — | — |
| CLYM | Bez oceny | 661,7M USD | — | — |
| STTK | C | 656,4M USD | — | — |
| PRTH | A | 642,2M USD | 11,46 | — |
| INDI | C | 622,3M USD | — | — |
| CTMX | F | 597M USD | — | — |
| VEL | A | 597M USD | 5,50 | — |
| AGNT | C | 594,9M USD | — | — |
| NRDS | A | 577,3M USD | 9,60 | — |
| IBEX | A | 576,2M USD | 13,86 | — |
| ALT | D | 575,8M USD | — | — |
| KELYA | F | 574,9M USD | — | — |
| JBI | D | 573M USD | 17,50 | — |
| GRNT | F | 566,5M USD | — | — |
| BRBI | F | 563,5M USD | — | — |
| CARS | A | 560,5M USD | 18,37 | — |
| PAR | B | 558,4M USD | — | — |
| ALLO | B | 558M USD | — | — |
| CBIO | D | 548,6M USD | — | — |
| PANL | C | 525,4M USD | 10,84 | — |
| SGHT | B | 514,5M USD | — | — |
| GAU | A | 513,1M USD | — | — |
| ISOU | Bez oceny | 511,4M USD | — | — |
| SLN | C | 509,3M USD | — | — |
| PBYI | B | 505,4M USD | 18,83 | — |
| DNUT | C | 502,3M USD | — | — |
| YORW | B | 498,7M USD | 19,09 | — |
| CERS | C | 497,8M USD | — | — |
| RGNX | D | 490,8M USD | — | — |
| MCFT | D | 488,5M USD | — | — |
| TKNO | B | 487M USD | — | — |
| OLP | B | 481,7M USD | 14,06 | — |
| KRUS | D | 474,3M USD | — | — |
| ULH | D | 464,1M USD | — | — |
| TECX | Bez oceny | 455,1M USD | — | — |
| WRN | Bez oceny | 452,2M USD | — | — |
| PRTA | C | 451M USD | — | — |
| VHI | A | 448,5M USD | — | — |
| TWI | D | 447,9M USD | — | — |
| TRC | C | 441,8M USD | 71,09 | — |
| ASPN | B | 433,6M USD | — | — |
| NATH | B | 415,9M USD | 21,01 | — |
| EVH | F | 399,1M USD | — | — |
| RZLT | Bez oceny | 395,6M USD | — | — |
| UWMC | D | 393,7M USD | — | — |
| TCI | D | 383,9M USD | 46,55 | — |
| CCCC | C | 383,8M USD | — | — |
| CARL | D | 383,6M USD | — | — |
| ADV | C | 379,2M USD | — | — |
| CCOI | D | 375,4M USD | — | — |
| RCEL | B | 370,2M USD | — | — |
| CLPT | D | 358,7M USD | — | — |
| CION | Bez oceny | 352,3M USD | — | — |
| LND | F | 350,2M USD | 12,87 | — |
| NL | B | 343,8M USD | — | — |
| TCPC | Bez oceny | 341,9M USD | — | — |
| REI | C | 336,1M USD | — | — |
| BIOA | D | 327,5M USD | — | — |
| ABAT | D | 312,2M USD | — | — |
| GOGO | F | 302,9M USD | — | — |
| TMCI | C | 300,1M USD | — | — |
| FNKO | B | 297,1M USD | — | — |
| RCKT | D | 284,3M USD | — | — |
| BKTI | A | 283,2M USD | 22,03 | — |
| RWAY | Bez oceny | 282,1M USD | 56,08 | — |
| ASLE | D | 281,9M USD | — | — |
| OPTU | F | 280,7M USD | — | — |
| ARL | D | 270,4M USD | 32,19 | — |
| HQI | D | 269,4M USD | 34,00 | — |
| STRO | F | 267,5M USD | — | — |
| KWY | F | 266,7M USD | — | — |
| KINS | A | 258,3M USD | 7,28 | — |
| CMRC | A | 257,7M USD | — | — |
| BLND | B | 255,2M USD | — | — |
| BRT | F | 252,8M USD | — | — |
| IVVD | C | 250,6M USD | — | — |
| ONIT | D | 250,3M USD | 1,90 | — |
| SIGA | F | 247,5M USD | — | — |
| CAMP | B | 245,4M USD | — | — |
| TRDA | F | 244,1M USD | — | — |
| LCTX | D | 242,7M USD | — | — |
| SSP | D | 237,3M USD | — | — |
| ZLAB | C | 229,6M USD | — | — |
| TBCH | C | 229M USD | — | — |
| NATR | C | 224,2M USD | 12,61 | — |
| NUS | D | 223,4M USD | — | — |
| GPRO | F | 221,6M USD | — | — |
| RNAC | F | 219M USD | — | — |
| WHWK | F | 213,2M USD | — | — |
| EXFY | F | 212,3M USD | — | — |
| ALEC | D | 209,9M USD | — | — |
| RC | F | 207,3M USD | — | — |
| FIRY | C | 200,1M USD | — | — |
| LCUT | C | 199,4M USD | 6,02 | — |
| ALTG | B | 193,7M USD | — | — |
| STRW | C | 183,8M USD | 19,97 | — |
| CHRS | B | 183,1M USD | — | — |
| CIA | D | 182,8M USD | — | — |
| ORGO | B | 178,2M USD | — | — |
| XPOF | F | 174,6M USD | — | — |
| AOMR | C | 174,6M USD | 10,16 | — |
| PRQR | C | 174,4M USD | — | — |
| WW | Bez oceny | 172,5M USD | — | — |
| FOCL | F | 171,1M USD | — | — |
| OPRX | C | 157,3M USD | 36,30 | — |
| CDXS | D | 148,4M USD | — | — |
| RANI | C | 144,5M USD | — | — |
| ONL | D | 142,6M USD | — | — |
| LDI | C | 139,5M USD | — | — |
| GHI | D | 135,7M USD | — | — |
| VERI | D | 132,6M USD | — | — |
| AMTX | C | 132,1M USD | — | — |
| CLAR | C | 131,7M USD | — | — |
| KVHI | D | 131,5M USD | — | — |
| NMRA | Bez oceny | 127,3M USD | — | — |
| SEER | D | 119M USD | — | — |
| JYNT | C | 110,2M USD | 28,85 | — |
| APYX | C | 109,7M USD | — | — |
| BDTX | D | 108M USD | — | — |
| TCX | B | 107,9M USD | — | — |
| OKUR | C | 105,1M USD | — | — |
| SOUN | D | 101,8M USD | — | — |
| CHMI | B | 100,1M USD | 10,35 | — |
| DH | D | 99,3M USD | — | — |
| HMR | A | 98,1M USD | — | — |
| GRWG | D | 92,8M USD | — | — |
| CRDF | F | 91,4M USD | — | — |
| CGTX | Bez oceny | 90,5M USD | — | — |
| RLYB | D | 89,5M USD | 3,43 | — |
| CCLD | B | 88,8M USD | 22,79 | — |
| LNSR | C | 85,4M USD | — | — |
| UBCP | C | 85,2M USD | 10,76 | — |
| BCIC | Bez oceny | 84,7M USD | — | — |
| SKIN | D | 82M USD | — | — |
| DTI | D | 81,3M USD | — | — |
| BLNK | C | 80,7M USD | — | — |
| MSC | C | 78,1M USD | — | — |
| ISPR | D | 75,9M USD | — | — |
| LONA | Bez oceny | 75,5M USD | — | — |
| SLQT | A | 75M USD | — | — |
| IOR | Bez oceny | 74,1M USD | 19,82 | — |
| UEIC | F | 67,6M USD | — | — |
| PLRX | D | 66,9M USD | — | — |
| INSG | F | 63,5M USD | — | — |
| CABO | F | 62M USD | — | — |
| TTEC | F | 61,1M USD | — | — |
| ALGS | D | 57,7M USD | — | — |
| FLL | A | 55,3M USD | — | — |
| LIDR | D | 55,3M USD | — | — |
| BZFD | F | 54,3M USD | — | — |
| STKS | B | 52,6M USD | — | — |
| SGA | F | 52,5M USD | — | — |
| KFFB | C | 52M USD | 37,82 | — |
| MKTW | D | 51,5M USD | 22,92 | — |
| MATH | B | 51,4M USD | 6,06 | — |
| OPAL | D | 51,3M USD | — | — |
| ACFN | C | 49,8M USD | 32,53 | — |
| SRTS | F | 49,7M USD | — | — |
| TEAD | F | 49,5M USD | — | — |
| FOUR | B | 49,4M USD | — | — |
| DWTX | Bez oceny | 45,6M USD | — | — |
| HGBL | F | 45M USD | — | — |
| SEAT | D | 44M USD | 3,49 | — |
| NEPH | C | 42,2M USD | 24,31 | — |
| PHUN | F | 40,9M USD | — | — |
| BAER | F | 36,9M USD | — | — |
| NTIP | F | 36,5M USD | — | — |
| HBIO | F | 36,5M USD | — | — |
| ELUT | F | 35,4M USD | 0,81 | — |
| UG | A | 33,2M USD | — | — |
| RAVE | A | 33,1M USD | 11,65 | — |
| ECHO | F | 31,6M USD | — | — |
| BHM | C | 31,2M USD | — | — |
| ATYR | F | 30,2M USD | — | — |
| MSGM | A | 25,4M USD | 11,69 | — |
| REFR | F | 23,4M USD | — | — |
| MERC | F | 21,5M USD | — | — |
| YARW | C | 20,6M USD | — | — |
| BIRD | D | 20,3M USD | — | — |
| LPCN | C | 17,7M USD | — | — |
| MDRR | F | 17,3M USD | 2,78 | — |
| PSQH | D | 17M USD | — | — |
| NEON | F | 14,8M USD | — | — |
| BRFH | D | 14,3M USD | — | — |
| LSTA | C | 13,1M USD | — | — |
| INAB | Bez oceny | 12,8M USD | — | — |
| INTS | Bez oceny | 11,2M USD | — | — |
| MTVA | Bez oceny | 11M USD | — | — |
| OXBR | C | 10,5M USD | — | — |
| UPLD | D | 9,4M USD | — | — |
| INUV | F | 8,9M USD | — | — |
| VEEE | D | 7,7M USD | — | — |
| INM | D | 7,6M USD | — | — |
| WHLR | D | 6,6M USD | — | — |
| PCSA | Bez oceny | 4,9M USD | — | — |
| REVB | Bez oceny | 3,3M USD | — | — |
| APVO | Bez oceny | 3,3M USD | — | — |
| AUUD | C | 2,8M USD | — | — |
| CRIS | F | 1,7M USD | — | — |
| VIVS | D | 1,1M USD | — | — |
| QNRX | Bez oceny | 997,3K USD | — | — |
| DRCT | F | 990,2K USD | — | — |
| KELYBnie pokrywamy | Bez oceny | — | — | — |
| LCLN | Bez oceny | — | — | — |
| NWSnie pokrywamy | Bez oceny | — | — | — |
| PLNT | A | — | — | — |
| UAnie pokrywamy | Bez oceny | — | — | — |
| VTVT | D | — | — | — |
| YOU | A | — | — | — |